| Cabozantinib Malate |
苹果酸卡博替尼 |
1140909-48-3 |
| BBI-608 |
1134099-70-9 |
1134099-70-9 |
| BBI-503(BB-503) |
AMCASERTIB |
1129403-56-0 |
| GSK1838705A |
GSK1838705A |
1116235-97-2 |
| Dacomitinib (PF299804) |
达克替尼 |
1110813-31-4 |
| 4-Quinazolinamine, N-cyclohexyl-2-cyclopropyl- |
化合物TH1085 |
1002801-51-5 |
| NADA |
NADA |
199875-69-9 |
| LDN-193189 |
LDN-193189 |
1062368-24-4 |
| WYE-354 |
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯 |
1062169-56-5 |
| LDN-193189 HCl |
LDN-193189 HCl |
1062368-62-0 |
| Tipifarnib |
替吡法尼 |
192185-72-1 |
| 4-(3-CHLOROPHENYL)-1,7-DIETHYLPYRIDO[2,3-D]PYRIMIDIN-2(1H)-ONE |
4-(3-CHLOROPHENYL)-1,7-DIETHYLPYRIDO[2,3-D]PYRIMIDIN-2(1H)-ONE |
191219-80-4 |
| NMS-P937 (NMS1286937) |
4,5-二氢-1-(2-羟基乙基)-8-[[5-(4-甲基-1-哌嗪基)-2-(三氟甲氧基)苯基]氨基]-1H-吡唑并[4,3-H]喹唑啉-3-甲酰胺 |
1034616-18-6 |
| LX-1606 Hippurate |
特罗司他乙酯 |
1033805-22-9 |
| Ceritinib (LDK378) |
色瑞替尼 |
1032900-25-6 |
| 2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene |
2-(2-甲基-5-溴苄基)-5-(4-氟苯)噻吩 |
1030825-20-7 |
| 5-[[4,5-Dimethoxy-2-(methylethyl)phenyl]methyl]-2,4-pyrimidinediamine |
5-[[4,5-Dimethoxy-2-(methylethyl)phenyl]methyl]-2,4-pyrimidinediamine |
1026582-88-6 |
| CC-122 |
3-(5-氨基-2-甲基-4-氧代喹唑啉-3(4H)-基)哌啶-2,6-二酮 |
1015474-32-4 |
| PF-04691502 |
2-氨基-8-[反式-4-(2-羟基乙氧基)环己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 |
1013101-36-4 |
| CARBAMIC ACID, N-[2-[(R)-(3-CHLOROPHENYL)[(3R)-1-[[[(2S)-2-(METHYLAMINO)-3-[(3R)-TETRAHYDRO-2H-PYRAN-3-YL]PROPYL]AMINO]CARBONYL]-3-PIPERIDINYL]METHOXY]ETHYL]-, METHYL ESTER, 2,2,2-TRIFLUOROACETATE (1:1) |
N-[2-[(R)-(3-氯苯基)[(3R)-1-[[[(2S)-2-(甲基氨基)-3-[(3R)-四氢-2H-吡喃-3-基]丙基]氨基]羰基]-3-哌啶基]甲氧基]乙基]氨基甲酸甲酯 2,2,2-三氟乙酸盐 |
1013937-63-7 |
